Our answer
What we do about it
The answer is never just the headline. Every finding comes with the mechanism behind it, how it has moved over recent quarters, the confounders we tested and ruled out, and an explicit account of what the data cannot tell you.
01
Your definitions, not ours
Cohort logic, line-of-therapy rules, competitor sets, and business rules come from you. The output reconciles with what you already report.
02
Sensitivity by default
Stratified and tested against the obvious alternative explanations before it reaches you: matched cohorts, replication across drug classes and age bands.
03
The exploratory pass
A scan across your market for what’s moving that nobody requested. Yours to bring to the brand team.
04
Limits stated, nothing to administer
What claims can’t see is written into every deliverable. No pipelines, no seat licences, no second source of truth.
Example analyses
- Cohort-matched benchmarks
- Sensitivity and robustness on an existing finding
- Exploratory market scan
- Intervention sizing
- Surge capacity on the request queue
A sample. If it’s in claims, it’s in scope.
The output is not a metric. It is a working understanding of your market — the kind you would otherwise assemble by hand, months after it had already shifted again — and a short, ordered list of where your attention should go first.